GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Stromacel PROT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Stromacel

Its shares trade under the ticker PROT. It has been listed since 31 July 1997. In the fiscal year to 31 December 2011, it reported revenue of $26,004 and a net loss of $1.4m. At that date it held total assets of $3.3m and shareholders' equity of −$3.7m.

Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. The company is headquartered in Mountainside, New Jersey. The firm is a subsidiary of Proteonomix Inc. The company offers technology in the field of cellular medicine to international clients. The firm intends to conduct phased human studies of its cellular materials in application to the treatment of cardiac and other diseases.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
31 Jul 1997
Employees
1

Leadership

Pay as last reported

  • Michael CohenChairman of the Board, President, Chief Executive Officer, Chief Operating Officer, since 2006$365,500
  • Mr. Thomas MonahanChief Financial Officer
  • Steven ByleChief Technical Officer, Director, since 2009
  • Dr. Ian McnieceVice President - Scientific Development , Chief Scientific Officer, Director, since 2009
  • Mr. Roger FidlerGeneral Counsel, Treasurer, Director, since 2010$23,750
  • Jason IsaacsCorporate Secretary$2,308

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.